Triple receptor agonists are an active area of metabolic research. Compounds in this class engage GLP-1, GIP, and glucagon receptors simultaneously. The pharmacology is documented in the published literature; this article summarizes the analytical considerations that matter when supplying these compounds for research.
Receptor profile
GLP-1 (glucagon-like peptide 1), GIP (gastric inhibitory polypeptide), and glucagon belong to the secretin receptor family. Triple agonists are designed to engage all three with varying affinity ratios. Each ratio produces a distinct pharmacological signature.
Analytical considerations
Purity verification by HPLC is mandatory. The signature of these compounds permits clean separation from common impurities at appropriate column conditions. Mass-spectrometric confirmation is recommended for analytical methods development; the COA accompanying each batch documents identity verification by retention time and MS where applicable.
Handling and stability
Long-term storage of the lyophilized powder at −20 °C is standard. Reconstituted material has limited stability. Bacteriostatic water (0.9% benzyl alcohol) is the conventional diluent for research applications. Avoid repeated freeze/thaw cycles.
For research use only. The information here describes documented pharmacology; it does not constitute a recommendation for any human or veterinary use.